Riskpilot← Back to searchSign inGet full accessMicromedic AB
ABActiveOrg 5569490153Ekbacksvägen 28Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201310 employees
Revenue 2024
SEK 58,8M
-15% vs 2023
EBITDA margin
-1.2%
-116% vs 2023
Equity ratio
32.8%
Financial strength
Net profit 2024
SEK -226K
-110% vs 2023
| Revenue | SEK 58,8M | -15% |
| EBITDA | SEK -687K | -116% |
| Net profit | SEK -226K | -110% |
| Total assets | SEK 35,9M | -13% |
| Equity | SEK 11,8M | -2% |
| Employees | 10 | — |
Legal name
Micromedic AB
Org number
5569490153
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15 november 2013
Share capital
SEK 1 000 000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas ensam av DØnås, Thormod
Company purpose
Aktiebolagets verksamhet ska vara parti- och detaljhandel med sjukvårds- och apoteksvaror, samt därmed förenlig verksamhet.
Address
Ekbacksvägen 28
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 61 440 | 62 671 | 52 316 | 45 974 | 59 487 | 69 256 | 58 767 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 762 | −489 | 1 488 | 6 242 | 3 734 | 1 099 | −1 570 | 3 575 | 4 207 | −687 |
| Depreciation & amort. | −0 | −0 | −3 | −0 | −0 | −47 | −48 | −62 | −67 | −67 |
| EBIT | 762 | −489 | 1 485 | 6 242 | 3 734 | 1 052 | −1 618 | 3 513 | 4 140 | −754 |
| Net financials | −133 | −138 | −235 | −467 | −424 | −224 | −12 | −444 | −80 | −719 |
| Profit before tax | 468 | −261 | 984 | 4 318 | 2 452 | 574 | −135 | 2 286 | 3 010 | −226 |
| Tax | −105 | −0 | −176 | −989 | −551 | −162 | −59 | −484 | −649 | −0 |
| Net profit | 363 | −261 | 808 | 3 329 | 1 901 | 412 | −194 | 1 802 | 2 361 | −226 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 14 883 | 21 677 | 47 147 | 52 664 | 34 381 | 28 728 | 27 791 | 37 482 | 41 137 | 35 890 |
| Equity | 1 843 | 1 582 | 2 389 | 5 719 | 7 620 | 8 033 | 7 839 | 9 641 | 12 002 | 11 776 |
| Long-term debt | 3 167 | 7 420 | 12 702 | 14 782 | 10 528 | 4 025 | 6 087 | 7 093 | 8 351 | 4 588 |
| Short-term debt | 9 507 | 12 675 | 31 789 | 30 440 | 13 651 | 13 837 | 12 526 | 18 626 | 17 612 | 17 602 |
| Total debt | 12 674 | 20 095 | 44 491 | 45 222 | 24 179 | 17 862 | 18 613 | 25 719 | 25 963 | 22 190 |
EBITDA margin
-1.2%
This company
15.8%
Market median
-108% vs market
20152024
Equity ratio
32.8%
This company
38.2%
Market median
+14% vs market
20152024
Return on equity
-1.9%
This company
18.4%
Market median
-110% vs market
20152024
Net profit margin
-0.4%
This company
8.1%
Market median
-105% vs market
20152024
Asset turnover
1.64×
This company
1.12×
Market median
+46% vs market
20152024
Debt / equity
2.05×
This company
0.62×
Market median
-231% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PO Authorized Recipient of Service | Authorized Recipient of Service | 2022 | — | — |
AG | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ORTOMEDIC AS | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ORTOMEDIC AS
Micromedic AB (this company)Board members of Micromedic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Ove Roland Göransson | Authorized Recipient of Service | 0 companies |
| Anders Gabriel Lundgren | Audit | 0 companies |
| Arvid Tjomsland | Board of Directors | 0 companies |
| Thormod Dønås | Chairman | 0 companies |
| Simen Gylterud Owe | Board of Directors | 0 companies |